Elsie Allen

2.6k total citations · 1 hit paper
20 papers, 2.1k citations indexed

About

Elsie Allen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Elsie Allen has authored 20 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Elsie Allen's work include Diabetes Treatment and Management (15 papers), Metabolism, Diabetes, and Cancer (10 papers) and Diabetes Management and Research (9 papers). Elsie Allen is often cited by papers focused on Diabetes Treatment and Management (15 papers), Metabolism, Diabetes, and Cancer (10 papers) and Diabetes Management and Research (9 papers). Elsie Allen collaborates with scholars based in United States, Germany and Philippines. Elsie Allen's co-authors include Holbrooke S. Seltzer, Priscilla Hollander, Roland Chen, Andreas Pfützner, Elizabeth Paz-Pacheco, Robert A. Gabbay, Peter Hu, Bruce W. Bode, Andrew Lewin and Philip Raskin and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Elsie Allen

19 papers receiving 1.9k citations

Hit Papers

Insulin Secretion in Response to Glycemic Stimulus: Relat... 1967 2026 1986 2006 1967 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*
    1967 671 citations Holbrooke S. Seltzer, Elsie Allen et al. Journal of Clinical Investigation profile →

Peers

Elsie Allen
Mark O’Neill United Kingdom
Maria Alba United States
Gianluca Bardini Italy
Mark Warren United States
Masashi Shimoda Japan
Helle Linnebjerg United States
P. D. Home United Kingdom
Frank Vercruysse United States
Freddy G. Eliaschewitz Brazil
Thomas Blevins United States
Mark O’Neill United Kingdom
Elsie Allen
Citations per year, relative to Elsie Allen Elsie Allen (= 1×) peers Mark O’Neill

Countries citing papers authored by Elsie Allen

Since Specialization
Citations

This map shows the geographic impact of Elsie Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsie Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsie Allen more than expected).

Fields of papers citing papers by Elsie Allen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsie Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsie Allen. The network helps show where Elsie Allen may publish in the future.

Co-authorship network of co-authors of Elsie Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Elsie Allen. A scholar is included among the top collaborators of Elsie Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsie Allen. Elsie Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kamble, Pravin, et al.. (2018). Understanding Prediabetes in a Medicare Advantage Population Using Data Adaptive Techniques. Population Health Management. 21(6). 477–485. 1 indexed citations
2.
Collins, Jenna, Ibrahim M. Abbass, Raymond A. Harvey, et al.. (2017). Predictors of all-cause 30 day readmission among Medicare patients with type 2 diabetes. Current Medical Research and Opinion. 33(8). 1517–1523. 33 indexed citations
3.
Ellis, Jeffrey J., et al.. (2016). A Historical Retrospective Analysis of the Impact of Diabetes Quality Measure Attainment on Outcomes in Medicare Advantage Members. Population Health Management. 20(2). 146–154. 1 indexed citations
4.
Schwab, Phil, Jonathan Bouchard, Neil Wintfeld, et al.. (2016). Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs. BMJ Open Diabetes Research & Care. 4(1). e000099–e000099. 15 indexed citations
5.
6.
Bryzinski, Brian, Elsie Allen, W. James Cook, & Boaz Hirshberg. (2014). Saxagliptin efficacy and safety in patients with type 2 diabetes receiving concomitant statin therapy. Journal of Diabetes and its Complications. 28(6). 887–893. 2 indexed citations
7.
8.
Karyekar, Chetan S., Mark Donovan, Elsie Allen, et al.. (2011). Efficacy and Safety of Saxagliptin Combination Therapy in US Patients with Type 2 Diabetes. Postgraduate Medicine. 123(4). 63–70. 14 indexed citations
9.
Pfützner, Andreas, et al.. (2011). Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks. Diabetes Obesity and Metabolism. 13(6). 567–576. 82 indexed citations
10.
Li, Jia, et al.. (2011). Safety and efficacy of saxagliptin added to thiazolidinedione over 76 weeks in patients with type 2 diabetes mellitus. Diabetes and Vascular Disease Research. 8(2). 125–135. 60 indexed citations
11.
Pfützner, Andreas, et al.. (2010). CV181‐039 Response Letter to G. Valiquette. Diabetes Obesity and Metabolism. 12(8). 735–735.
12.
Maheux, Pierre, Elsie Allen, Shoba Ravichandran, James F. List, & Roland Chen. (2009). Saxagliptin added to a thiazolidinedione, metformin or a sulphonylurea improves glycaemic control in patients with inadequately controlled type 2 diabetes mellitus. 3 indexed citations
13.
14.
Hollander, Priscilla, et al.. (2009). Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone. The Journal of Clinical Endocrinology & Metabolism. 94(12). 4810–4819. 185 indexed citations
15.
Garber, A. J., Tyler S. Wahl, Peter Bressler, et al.. (2005). Attainment of glycaemic goals in type 2 diabetes with once‐, twice‐, or thrice‐daily dosing with biphasic insulin aspart 70/30 (The 1‐2‐3 study). Diabetes Obesity and Metabolism. 8(1). 58–66. 193 indexed citations
16.
Raskin, Philip, Elsie Allen, Priscilla Hollander, et al.. (2005). Initiating Insulin Therapy in Type 2 Diabetes. Diabetes Care. 28(2). 260–265. 432 indexed citations
17.
Warren, Mark, Martin J. Conway, Leslie J. Klaff, Julio Rosenstock, & Elsie Allen. (2004). Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients. Diabetes Research and Clinical Practice. 66(1). 23–29. 45 indexed citations
18.
Seltzer, Holbrooke S. & Elsie Allen. (1969). Hyperglycemia and Inhibition of Insulin Secretion during Administration of Diazoxide and Trichlormethiazide in Man. Diabetes. 18(1). 19–28. 22 indexed citations
19.
Seltzer, Holbrooke S., et al.. (1967). Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*. Journal of Clinical Investigation. 46(3). 323–335. 671 indexed citations breakdown →
20.
Seltzer, Holbrooke S., et al.. (1965). Failure of Prolonged Sulfonylurea Administration to Enhance Insulogenic Response to Glycemic Stimulus. Diabetes. 14(7). 392–395. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark O’Neill Breakdown of academic impact, for papers by Maria Alba Breakdown of academic impact, for papers by Gianluca Bardini Breakdown of academic impact, for papers by Mark Warren Breakdown of academic impact, for papers by Masashi Shimoda Breakdown of academic impact, for papers by Helle Linnebjerg Breakdown of academic impact, for papers by P. D. Home Breakdown of academic impact, for papers by Frank Vercruysse Breakdown of academic impact, for papers by Freddy G. Eliaschewitz Breakdown of academic impact, for papers by Thomas Blevins
Rankless by CCL
2026